Sunesis Pharmaceuticals Stock Price - SNSS

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sunesis Pharmaceuticals Inc SNSS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0008 0.14% 0.5908 0.63 0.59 0.62 0.59 09:38:46
Bid Price Ask Price Spread Spread % News
0.5901 0.5979 0.0079 1.32% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
217 77,236 $ 0.602475 $ 46,533 453,778 0.20 - 1.9799
Last Trade Time Type Quantity Stock Price Currency
09:38:46 1,708 $ 0.5908 USD

Sunesis Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 65.77M 111.32M $ -26.62M -0.75 - 109.33M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 1.80%

more financials information »

Sunesis Pharmaceuticals News

Date Time Source News Article
10/16/201916:59GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510..
10/01/201914:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/27/201917:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
9/19/201916:17Edgar (US Regulatory)Current Report Filing (8-k)
9/19/201907:00GlobeNewswire Inc.Sunesis Pharmaceuticals Appoints Dr. Nicole Onetto to the..
8/28/201907:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the Wells Fargo..
8/12/201916:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest SNSS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNSS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.62480.670.55030.6097489k-0.034-5.44%
1 Month0.80590.90.55030.6984348k-0.2151-26.69%
3 Months0.721.08290.55030.8366407k-0.1292-17.94%
6 Months1.281.57880.55030.8758752k-0.6892-53.84%
1 Year1.931.97990.20.8702708k-1.3392-69.39%
3 Years4.47.690.21.5770337k-3.8092-86.57%
5 Years1.427.690.21.7719555k-0.8292-58.39%

Sunesis Pharmaceuticals Description

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.
Your Recent History
Sunesis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191017 13:53:46